Implementing a federal nicotine reduction strategy may prevent millions of premature deaths, boost productivity, and significantly close smoking disparity gaps for individuals with major depression, according to Rutgers Health researchers.

In their first two years after graduation, resident doctors are currently twice as likely as other healthcare professionals to make prescribing errors. However, new evidence presented by Taylor & Francis during Sense about Science Evidence Week demonstrates that incorporating structured, video-enhanced feedback into training programs can dramatically reduce these mistakes.

Liver disease may affect close to half of adults in Mexico, yet the country tracks it far less closely than the diabetes and obesity to which it is linked, according to a new paper by Jeffrey Lazarus, professor at the CUNY Graduate School of Public Health and Health Policy Professor (CUNY SPH), and colleagues, and released to coincide with the International Congress on Obesity taking place in Mexico City this week. The authors argue Mexico should fold liver health into its existing programs for diabetes, obesity, and other noncommunicable diseases rather than treating it as a separate problem.

The U.S. Sentencing Guidelines are of pivotal importance to what are collectively among the most consequential drug policy decisions made by the federal government. Two recurring themes have been the balancing—or lack of balancing—between drug weight and the defendant’s role in the drug distribution enterprise, and the basis for judging what relative weights of different drugs should be treated similarly. In a new article, researchers suggest approaches to these questions that offer constructive steps without jettisoning the overall approach.